2021/01/11 09:17 Packaging for Sinopharm vaccine. (CNA photo) Packaging for Sinopharm vaccine. (CNA photo) TAIPEI (Taiwan News) Amid increasing concern about the efficacy and safety of China s Wuhan coronavirus vaccines, the full list of the adverse side effects of the Sinopharm jab surfaced last week. Shanghai-based vaccine expert Tao Lina (陶黎納) on Jan. 4 uploaded to Weibo a digital version of the manual for BBIBP-CorV, an inactivated vaccine produced by China National Biotec Group (CNBG), a subsidiary of China National Pharmaceutical Group Corporation (Sinopharm). In his post, he described the vaccine as the most unsafe vaccine in the world due to its 73 local and systemic adverse reactions.
A Chinese vaccine expert has allegedly called Sinopharm s COVID-19 vaccine the most unsafe in the world , claiming that it has 73 side effects. The inactivated vaccine, BBIBP-CorV, is produced by China National Biotec Group (CNBG), a subsidiary of China National Pharmaceutical Group Corporation (Sinopharm).
The vaccine was officially approved by China s National Medical Products Administration on December 30, 2020, for general use in the country. Sinopharm announced last month that phase three trials of the vaccine showed that it was 79 percent effective against the Coronavirus caused disease.
However, Dr. Tao Lina, a Shanghai-based vaccine expert, claimed in his Weibo page that the jab, developed by Beijing s state-run drugmaker, had 73 side effects, reported Hong Kong s Ming Pao newspaper. After his claims went viral outside mainland China, Dr. Tao s Weibo account was deleted by the authorities. Now, his page states this content cannot be viewed due to violation of regulations.
2021/01/06 18:38 (Weibo screenshot) (Weibo screenshot) TAIPEI (Taiwan News) A Chinese vaccine expert is referring to the vaunted Sinopharm vaccine as the most unsafe vaccine in the world, after it was found to produce 73 side effects. On Dec. 30 of last year, BBIBP-CorV, an inactivated vaccine produced by China National Biotec Group (CNBG), a subsidiary of China National Pharmaceutical Group Corporation (Sinopharm), was officially approved by China s National Medical Products Administration for general use in the communist country. This was the first Wuhan coronavirus vaccine approved by the Chinese government, and the state-run firm claimed that it has an efficacy rate of 79.34 percent based on late-stage trials.
Year ender - Indonesia takes cautious steps towards mass immunization 29th December 2020
FILE PHOTO: A display shows packages of vaccine candidate for SARS-CoV-2 by Sinovac Biotech during a government-organized media tour showcasing the company s development of a coronavirus disease (COVID-19) vaccine candidate in Beijing, China, September 24, 2020. REUTERS/Thomas Peter/File Photo (REUTERS/Thomas Peter) With still no emergency-use approval for Sinovac’s COVID-19 vaccine, it is becoming increasingly evident that the Indonesian government will have to wait until 2021 to kickstart its mass vaccination program.
Initially, the government had hoped to begin the vaccination program in the third week of December, 2020, with healthcare workers and legal enforcers getting first priority.
SunStar
253936 December 29, 2020 HEALTH officials on Tuesday, December 29, 2020, said the people who imported and distributed the unregistered Sinopharm vaccine against coronavirus disease 2019 (Covid-19) will face sanctions.
Department of Health (DOH) Undersecretary Maria Rosario Vergeire said the sale, distribution or supply of a product that is not registered with the Food and Drug Administration (FDA) violate Republic Act 9711. Those who brought in this vaccine, those who have supplied or distributed, and even the manufacturer may be sanctioned if they are used by our population without the proper processing by our regulatory agency, which is FDA,” Vergeire said in a virtual press briefing on Tuesday.